EXOPRODUCT SECRETIONS OF PSEUDOMONAS-AERUGINOSA STRAINS INFLUENCE SEVERITY OF ALVEOLAR EPITHELIAL INJURY

被引:83
作者
KUDOH, I
WIENERKRONISH, JP
HASHIMOTO, S
PITTET, JF
FRANK, D
机构
[1] UNIV CALIF SAN FRANCISCO, DEPT ANESTHESIA, SAN FRANCISCO, CA 94143 USA
[2] UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA
[3] UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA
[4] MED COLL WISCONSIN, DEPT MICROBIOL, MILWAUKEE, WI 53226 USA
[5] YOKOHAMA CITY UNIV, SCH MED, DEPT ANESTHESIOL, YOKOHAMA, KANAGAWA 236, JAPAN
关键词
EXOTOXIN A; EXOENZYME S; ALVEOLAR EPITHELIAL INJURY; PAK; PA103;
D O I
10.1152/ajplung.1994.267.5.L551
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
To determine whether exoenzyme S plays a role in alveolar epithelial injury, two parental strains of Pseudomonas aeruginosa, PAK and PA103, were tested that produced large quantities of exoenzyme S. Strains PAK and PA103 differ in the form of exoenzyme S they produce. Strain PAK produces a 53-kDa protein that does not possess ADP-ribosyltransferase activity and large quantities of a 49-kDa protein that expresses ADP-ribosyltransferase activity. Strain PA103 produces the 53-kDa protein and low amounts of exoenzyme S activity. A quantitative experimental protocol was used to measure the protein permeability of the alveolar epithelium and the dissemination of the bacteria to the pleural space and circulation. The results indicate that instillation of PAK and PA103 resulted in significant lung injury. Control experiments utilizing isogenic, exoenzyme S-deficient, regulatory mutants in the infection model reduced the lung injury and the dissemination of instilled bacteria. Taken together these results suggest that alveolar epithelial injury correlated with the production of the 53-kDa form of exoenzyme S or other coordinately regulated factors.
引用
收藏
页码:L551 / L556
页数:6
相关论文
共 17 条
  • [1] ALVEOLAR LIQUID AND PROTEIN CLEARANCE FROM NORMAL DOG LUNGS
    BERTHIAUME, Y
    BROADDUS, VC
    GROPPER, MA
    TANITA, T
    MATTHAY, MA
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1988, 65 (02) : 585 - 593
  • [2] COBURN J, 1989, J BIOL CHEM, V264, P9004
  • [3] CONSTRUCTION AND CHARACTERIZATION OF CHROMOSOMAL INSERTIONAL MUTATIONS OF THE PSEUDOMONAS-AERUGINOSA EXOENZYME-S TRANSREGULATORY LOCUS
    FRANK, DW
    NAIR, G
    SCHWEIZER, HP
    [J]. INFECTION AND IMMUNITY, 1994, 62 (02) : 554 - 563
  • [4] PURIFICATION AND CHARACTERIZATION OF EXOENZYME-S FROM PSEUDOMONAS-AERUGINOSA-388
    KULICH, SM
    FRANK, DW
    BARBIERI, JT
    [J]. INFECTION AND IMMUNITY, 1993, 61 (01) : 307 - 313
  • [5] THE ROLE OF EXOENZYME-S IN INFECTIONS WITH PSEUDOMONAS-AERUGINOSA
    NICAS, TI
    BRADLEY, J
    LOCHNER, JE
    IGLEWSKI, BH
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (04) : 716 - 721
  • [6] THE CONTRIBUTION OF EXOPRODUCTS TO VIRULENCE OF PSEUDOMONAS-AERUGINOSA
    NICAS, TI
    IGLEWSKI, BH
    [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1985, 31 (04) : 387 - 392
  • [7] ISOLATION AND CHARACTERIZATION OF TRANSPOSON-INDUCED MUTANTS OF PSEUDOMONAS-AERUGINOSA DEFICIENT IN PRODUCTION OF EXOENZYME-S
    NICAS, TI
    IGLEWSKI, BH
    [J]. INFECTION AND IMMUNITY, 1984, 45 (02) : 470 - 474
  • [8] NICAS TI, 1988, ANTIBIOT CHEMOTHER B, V36, P40
  • [9] PSEUDOMONAS-AERUGINOSA INDUCED LUNG AND PLEURAL INJURY IN SHEEP - DIFFERENTIAL PROTECTIVE EFFECT OF CIRCULATING VERSUS ALVEOLAR IMMUNOGLOBULIN-G ANTIBODY
    PITTET, JF
    MATTHAY, MA
    PIER, G
    GRADY, M
    WIENERKRONISH, JP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) : 1221 - 1228
  • [10] INVITRO INSERTIONAL MUTAGENESIS WITH A SELECTABLE DNA FRAGMENT
    PRENTKI, P
    KRISCH, HM
    [J]. GENE, 1984, 29 (03) : 303 - 313